Indian Army pharmaceutical tender for Oncology/Infectious Drugs & Anticancer Injectables in India 2026
Bid Publish Date
09-Jul-2026, 11:01 am
Bid End Date
06-Aug-2026, 11:00 am
EMD
₹4,42,260
Location
Progress
RAKey Highlights
- • Indigenous drugs shelf-life preference: 5/6 of shelf life remaining at supply
- • 50% quantity option during and after contract with contracted rates
- • BBQR compliance mandatory with exclusive supplier documentation
- • OEM Authorization Certification and past performance required
- • Stock replacement obligation: unconsumed stock before expiry; defectives replaced
- • Submission routed to OIC GeM (Med), Command Hospital (EC), Alipore, Kolkata
- • No substitutions with health supplements unless explicitly requested
- • EMD amount: ₹442,260; 23-line-item BBQR-consistent scope
Tender Overview
The Indian Army, Department Of Military Affairs, invites bids for a broad range of oncology injectables and related medical items across 23 line items, including Paclitaxel, Carboplatin, 5-Fluorouracil, Cisplatin, Docetaxel, Pegylated Liposomal Doxorubicin, Doxorubicin, Ifosfamide, Mesna, Vincristine, Bleomycin, Pemetrexed, Irinotecan, Epirubicin, Axitinib, Pertuzumab and Trastuzumab. The procurement aims to ensure medical continuity for combat and casualty care. The estimated value is not disclosed; the EMD is ₹442,260. The BBQR specification and supplier compliance are mandatory, with a required brochure before bid opening and OEM authorizations. Shelf-life treatment favors indigenous drugs with 5/6 of shelf life remaining; foreign products must maintain 2/3. A delivery and stock replacement policy governs remaining stock and defective items. Location for submission is Kolkata, with strict adherence to BBQR for 23 items and exclusive use of medicines rather than health supplements.
Technical Specifications & Requirements
- Product categories: Oncology injectables and chemotherapeutic agents; includes Paclitaxel 100 mg Inj, Paclitaxel 30 mg Inj, Carboplatin 150 mg Inj, 5-Fluorouracil 500 mg/10 ml Inj, Cisplatin 50 mg Inj, Docetaxel variants, Doxorubicin formulations, Bleomycin, Ifosfamide, Mesna, Vincristine, Pemetrexed, Irinotecan, Ep irubicin, Axitinib 5 mg, and Pertuzumab/Trastuzumab 600 mg each.
- Standards / compliance: BBQR-compliant; indigenous drugs shelf-life policy; OEM authorization; MII / past performance documents; exclusive compliance with BBQR specifications; no substitutes for medicines unless explicitly asked; stock replacement within 3 months of expiry; warranty/defect replacement obligations.
- Delivery / scope: 23 items with delivery in line with original delivery order; option to increase quantity up to 50% during contract at contracted rates; extended delivery period rules apply if options exercised; address for brochure submission via GeM Med channel is Kolkata.
- Documentation: OEM authorization, turnover evidence, past performance, and compliance certificates must be uploaded; brochure submission to OIC GeM (Med), Command Hospital (EC), Alipore, Kolkata.
Terms, Conditions & Eligibility
- EMD: ₹442,260 to be submitted as specified in tender terms.
- Option clause: quantity may increase/decrease by up to 50%; delivery periods extend proportionally with a minimum of 30 days.
- Shelf-life policy: indigenous drugs keep 5/6th of shelf life; foreign products maintain 2/3; acceptance at CFA discretion.
- Replacement: replace unconsumed stock before expiry; replace defective stock within shelf life.
- Documentation: submit GST, PAN, OEM authorizations, experience, financials, and BBQR compliance; failure results in rejection.
- Delivery / payment terms: terms aligned with BBQR; no health supplements in place of medicines unless requested.
Key Specifications
-
23 items spanning chemotherapy injectables and anticancer agents
-
Exact drug forms listed in tender data (e.g., Paclitaxel 100 mg Inj, Docetaxel 80 mg, Pegylated Liposomal Doxorubicin 20 mg Inj, etc.)
-
Shelf-life policy: indigenous vs foreign stock remaining life on delivery
-
BBQR specification mandatory with full compliance
-
OEM authorization and past performance requirements
-
Delivery period linked to original delivery order with option-based extension
Terms & Conditions
-
EMD amount ₹442,260; submission channel per BBQR terms
-
Quantity may vary up to 50% with proportional delivery time
-
Indigenous stock shelf-life policy governs acceptance
Important Clauses
Payment Terms
BBQR-aligned payments; EMD bundled amount; no mention of credit terms beyond BBQR
Delivery Schedule
Delivery begins from last date of original order; extended period applies with option clause
Penalties/Liquidated Damages
Not explicitly detailed; governs stock replacement and shelf-life compliance via CFA/BBQR terms
Bidder Eligibility
-
Experience in supplying oncology injectables and related chemotherapy drugs
-
BBQR compliance with supplier documentation
-
OEM authorization and annual turnover sufficient to meet tender scope
Reverse Auction Schedule
Start
04-Sep-2026, 4:00 pm
End
05-Sep-2026, 4:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Tender Data
Bid Details
Quantity
16272
Category
Paclitaxel 100mg Inj
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Item wise evaluation
Inspection Required
No
RA Qualification Rule
H1-Highest Priced Bid Elimination
Tech Clarification Time
2 Days
Preference & Exemptions
EMD Required
Yes
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Requirements
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Paclitaxel 100mg Inj , Paclitaxel 30 mg Inj , Albumin bound Paclitaxel 100 mg , Inj Nano Paclitaxel 300 mg , Carboplatin 150 mg Inj , 5-Fluorouracil 500mg, 10 ml Inj , Cisplatin 50mg Inj , inj TPGS Docetaxel 20 mg , inj TPGS Docetaxel 80 mg , inj TPGS Docetaxel 120 mg , Docetaxel 80mg per 2ml vial 6 ml solvent for Inj , Docetaxel 20 mg 0.5ml vial plus 1.5 ml Solvent for Inj , Pegylated Liposomal Doxorubicin 20mg Inj , Doxorubicin HCl 2mg per ml, 5ml Inj , Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna , Mesna 200mg Inj , Vincristine Sulphate 1mg Inj , Bleomycin Sulphate per Chloride 15mg Inj , Inj Pemetrexed 100 mg , Inj Irinotecan 100mg , Epirubicin 50 mg Inj vial of 50 mg , Tab Axitinib 5 mg , Inj Pertuzumab 600mg plus Trastuzumab 600mg
Advisory Bank
State Bank of India
ePBG Percentage
5%
ePBG Duration (Months)
6
Delivery Details
Max Delivery Days
30
Delivery Locations
1
Delivery Cities
Kolkata
Delivery Locations
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | Kolkata | Kolkata | - | - | 900 | 30 | - |
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 5
GeM-Bidding-9381933.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Other Documents
OTHER
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
23 Items Sign in to view GEM price trends Sign in for GEM prices
Paclitaxel 100mg Inj
Paclitaxel 100mg Inj
Paclitaxel 30 mg Inj
Paclitaxel 30 mg Inj
Albumin bound Paclitaxel 100 mg
Albumin bound Paclitaxel 100 mg
Inj Nano Paclitaxel 300 mg
Inj Nano Paclitaxel 300 mg
Carboplatin 150 mg Inj
Carboplatin 150 mg Inj
5-Fluorouracil 500mg, 10 ml Inj
5-Fluorouracil 500mg, 10 ml Inj
Cisplatin 50mg Inj
Cisplatin 50mg Inj
inj TPGS Docetaxel 20 mg
inj TPGS Docetaxel 20 mg
inj TPGS Docetaxel 80 mg
inj TPGS Docetaxel 80 mg
inj TPGS Docetaxel 120 mg
inj TPGS Docetaxel 120 mg
Docetaxel 80mg per 2ml vial 6 ml solvent for Inj
Docetaxel 80mg/2ml vial 6 ml solvent for Inj
Docetaxel 20 mg 0.5ml vial plus 1.5 ml Solvent for Inj
Docetaxel 20 mg 0.5ml vial + 1.5 ml Solvent for Inj
Pegylated Liposomal Doxorubicin 20mg Inj
Pegylated Liposomal Doxorubicin 20mg Inj
Doxorubicin HCl 2mg per ml, 5ml Inj
Doxorubicin HCl 2mg/ml, 5ml Inj
Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna
Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna
Mesna 200mg Inj
Mesna 200mg Inj
Vincristine Sulphate 1mg Inj
Vincristine Sulphate 1mg Inj
Bleomycin Sulphate per Chloride 15mg Inj
Bleomycin Sulphate/Chloride 15mg Inj
Inj Pemetrexed 100 mg
Inj Pemetrexed 100 mg
Inj Irinotecan 100mg
Inj Irinotecan 100mg
Epirubicin 50 mg Inj vial of 50 mg
Epirubicin 50 mg Inj vial of 50 mg
Tab Axitinib 5 mg
Tab Axitinib 5 mg
Inj Pertuzumab 600mg plus Trastuzumab 600mg
Inj Pertuzumab 600mg + Trastuzumab 600mg
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Paclitaxel 100mg Inj | Paclitaxel 100mg Inj | 900 | vial | consignee2dglp | 30 | |
| 2 | Paclitaxel 30 mg Inj | Paclitaxel 30 mg Inj | 900 | amp or vial | consignee2dglp | 30 | |
| 3 | Albumin bound Paclitaxel 100 mg | Albumin bound Paclitaxel 100 mg | 300 | vial | consignee2dglp | 30 | |
| 4 | Inj Nano Paclitaxel 300 mg | Inj Nano Paclitaxel 300 mg | 120 | vail | consignee2dglp | 30 | |
| 5 | Carboplatin 150 mg Inj | Carboplatin 150 mg Inj | 1,500 | vial | consignee2dglp | 30 | |
| 6 | 5-Fluorouracil 500mg, 10 ml Inj | 5-Fluorouracil 500mg, 10 ml Inj | 1,800 | amp or vial | consignee2dglp | 30 | |
| 7 | Cisplatin 50mg Inj | Cisplatin 50mg Inj | 900 | amp or vial | consignee2dglp | 30 | |
| 8 | inj TPGS Docetaxel 20 mg | inj TPGS Docetaxel 20 mg | 120 | no | consignee2dglp | 30 | |
| 9 | inj TPGS Docetaxel 80 mg | inj TPGS Docetaxel 80 mg | 120 | no | consignee2dglp | 30 | |
| 10 | inj TPGS Docetaxel 120 mg | inj TPGS Docetaxel 120 mg | 120 | no | consignee2dglp | 30 | |
| 11 | Docetaxel 80mg per 2ml vial 6 ml solvent for Inj | Docetaxel 80mg/2ml vial 6 ml solvent for Inj | 180 | amp or vial | consignee2dglp | 30 | |
| 12 | Docetaxel 20 mg 0.5ml vial plus 1.5 ml Solvent for Inj | Docetaxel 20 mg 0.5ml vial + 1.5 ml Solvent for Inj | 360 | amp or vial | consignee2dglp | 30 | |
| 13 | Pegylated Liposomal Doxorubicin 20mg Inj | Pegylated Liposomal Doxorubicin 20mg Inj | 120 | vial | consignee2dglp | 30 | |
| 14 | Doxorubicin HCl 2mg per ml, 5ml Inj | Doxorubicin HCl 2mg/ml, 5ml Inj | 600 | amp or vial | consignee2dglp | 30 | |
| 15 | Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna | Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna | 600 | amp or vial | consignee2dglp | 30 | |
| 16 | Mesna 200mg Inj | Mesna 200mg Inj | 4,200 | amp or vial | consignee2dglp | 30 | |
| 17 | Vincristine Sulphate 1mg Inj | Vincristine Sulphate 1mg Inj | 300 | amp or vial | consignee2dglp | 30 | |
| 18 | Bleomycin Sulphate per Chloride 15mg Inj | Bleomycin Sulphate/Chloride 15mg Inj | 180 | amp or vial | consignee2dglp | 30 | |
| 19 | Inj Pemetrexed 100 mg | Inj Pemetrexed 100 mg | 300 | vial | consignee2dglp | 30 | |
| 20 | Inj Irinotecan 100mg | Inj Irinotecan 100mg | 300 | vial | consignee2dglp | 30 | |
| 21 | Epirubicin 50 mg Inj vial of 50 mg | Epirubicin 50 mg Inj vial of 50 mg | 120 | vial | consignee2dglp | 30 | |
| 22 | Tab Axitinib 5 mg | Tab Axitinib 5 mg | 2,160 | no | consignee2dglp | 30 | |
| 23 | Inj Pertuzumab 600mg plus Trastuzumab 600mg | Inj Pertuzumab 600mg + Trastuzumab 600mg | 72 | vial | consignee2dglp | 30 |
Categories
2
Corrigendum Updates
1 Update Update
Extended Deadline
06-Aug-2026, 5:30 am
Opening Date
06-Aug-2026, 6:00 am
Required Documents
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates for similar supply
Financial statements / turnover details
EMD/Security deposit documentation (₹442,260)
Technical bid documents and BBQR compliance sheets
OEM Authorization Certificate
Past performance certificates
Company profile and MII documents (as applicable)
BBQR brochure and compliance uploads
Frequently Asked Questions
Key insights about WEST BENGAL tender market
How to bid for the oncology injectables tender in Kolkata 2026?
Bidders must submit BBQR-compliant documents, OEM authorization, past performance proofs, GST and PAN, and EMD of ₹442,260. Upload the BBQR-compliant brochure before bid opening and ensure indigenous shelf-life rules apply. Follow GeM Med submission route to Command Hospital (EC), Alipore, Kolkata.
What documents are required for the Indian Army drug procurement bid 2026?
Required documents include GST certificate, PAN card, Experience certificates, Financial statements, EMD documentation (₹442,260), Technical bid, OEM Authorization Certificate, and BBQR compliance sheets; ensure stock replacement commitments and shelf-life disclosures are included.
What are the technical specifications for the listed drugs in this tender?
The tender lists multiple chemotherapeutic agents by brand/form; ensure BBQR compliance, correct dosage forms (e.g., Paclitaxel 100 mg Inj, Docetaxel variants), and shelf-life adherence. Exact numerical dosages are as named in the item list; verify with OEM certificates.
When is the delivery timeline for quantity variations under the option clause?
Delivery terms allow a quantity variation up to 50%; delivery period adjusts proportionally to the new quantity, with a minimum of 30 days; original delivery period governs initial scheduling. Extended delivery relies on option exercise timing.
What is the shelf-life policy for indigenous and foreign drugs in this tender?
Indigenous drugs must have 5/6 of shelf life remaining at supply, while foreign products require 2/3. CFA/BBQR terms govern acceptance; retailer stock must be replaced before expiry per clauses 7–8.
What is the role of OEM authorization in the bidding process?
An OEM Authorization Certificate is mandatory, along with OEM annual turnover and past performance records. The certificate confirms authorized supply of listed oncology drugs and adherence to quality standards, enabling eligibility for Technical Evaluation Committee review.
How to ensure BBQR compliance for this Indian Army procurement?
Upload the BBQR compliance brochure and ensure all 23 item specifications align with BBQR; non-compliance risks bid rejection. Include MII, experience, performance data, and supplier compliance documents as part of the Tech Bid.
What are the penalties or remedies for stock defects or expiry delays?
Stock replacement obligations exist for unconsumed or defective items; shelf-life compliance is monitored by CFA/BBQR terms. Penalties are tied to stock quality and timely replacement, with decisions binding on bidders by the Technical Evaluation Committee.